Heart Failure Precision Medicine Study
Recruiting · NCT04196842 · Interventional (participants receive a specific treatment) · Lead sponsor: University of California, Davis
View the official record on ClinicalTrials.gov →Interventions studied
Telemonitoring devices
What this trial is about
The study aims to test the hypothesis that multi-omics studies can identify Heart Failure profiles at risk of adverse outcomes and evaluate a telemonitoring intervention in the optimization of guideline-directed medical therapy.
Who can take part
Age range
21 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Diagnosis of Heart failure
- Objective evidence of cardiac abnormality of structure or function (abnormal ECHO) or elevated levels of B-type natriuretic peptide (\>100 pg/ml)
- HF stage B-D and class I-IV
Exclusion criteria
- Patients unable to consent
- Inability to comply with the protocol and follow-up requirements
- Patients unable to use a smartphone
- Patients assessed irregularly (less than two visits in one year)
- History of HTx
- Use of Mechanical circulatory support device (MCSD)
- Comorbidities that, according to the PI, have the potential to interfere with the interpretation of the results
Where it is running
1 location listed across 1 US state.
- UC Davis Medical Center - Sacramento, California, United States